You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NAD precursor

Showing 1 - 25 of 551
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Friedreich Ataxia Trial in Philadelphia (MIB-626)

Active, not recruiting
  • Friedreich Ataxia
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Oct 26, 2022

Friedreich Ataxia 1 Trial in Philadelphia (Nicotinamide Riboside, Placebo, Exercise Intervention)

Recruiting
  • Friedreich Ataxia 1
  • Nicotinamide Riboside
  • +2 more
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Sep 21, 2022

Acute Lymphoblastic Leukemia in Remission, Cancer Survivors Trial in Duarte, Philadelphia (Nicotinamide Riboside, Placebo,

Recruiting
  • Acute Lymphoblastic Leukemia in Remission
  • Cancer Survivors
  • Nicotinamide Riboside
  • +2 more
  • Duarte, California
  • +1 more
Jun 21, 2022

Aging, Mitochondrial Function Trial in Maastricht (NAD-precursors, Control)

Terminated
  • Aging
  • Mitochondrial Function
  • NAD-precursors
  • Control
  • Maastricht, Limburg, Netherlands
    Maastricht University
Aug 18, 2020

NAD Trial in Berlin (Niagen, Placebo)

Not yet recruiting
  • NAD
  • Niagen
  • Placebo
  • Berlin, Germany
    Surgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte,
Aug 22, 2023

Enhance Immune Function Trial (NMN)

Not yet recruiting
  • Enhance Immune Function
  • (no location specified)
Aug 2, 2023

Cognitive Impairment, Sleep Quality Trial in Buffalo (Nicotinamide riboside, Placebo)

Not yet recruiting
  • Cognitive Impairment
  • Sleep Quality
  • Nicotinamide riboside
  • Placebo
  • Buffalo, New York
  • +1 more
Aug 10, 2022

Gulf War Illness Trial in Fort Lauderdale, Sarasota (Nicotinamide Riboside, Placebo)

Recruiting
  • Gulf War Illness
  • Nicotinamide Riboside
  • Placebo
  • Fort Lauderdale, Florida
  • +1 more
Apr 25, 2022

Postoperative Prevention of Tumor Trial in Shanghai (Oral NMN combined with DC cell vaccine)

Not yet recruiting
  • Postoperative Prevention of Tumor
  • Oral NMN combined with DC cell vaccine
  • Shanghai, Shanghai, China
    Shanghai Mengchao Cancer Hospital
Sep 6, 2023

Mild Cognitive Impairment, NAD Trial in San Antonio (Nicotinamide riboside, Sugar Pill)

Completed
  • Mild Cognitive Impairment
  • NAD
  • Nicotinamide riboside
  • Sugar Pill
  • San Antonio, Texas
  • +1 more
Aug 31, 2021

COPD Trial in Copenhagen (Nicotinamide Riboside, Placebo)

Recruiting
  • COPD
  • Nicotinamide Riboside
  • Placebo
  • Copenhagen, Denmark
    Respiratory Research Unit, Bispebjerg Hospital
Jul 26, 2021

Alzheimer's Disease (Incl Subtypes), Dementia Trial in Boston (MIB-626, Placebo)

Recruiting
  • Alzheimer's Disease (Incl Subtypes)
  • Dementia
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 11, 2022

Vascular Diseases, Kidney Disease, Blood Pressure Trial in Aurora (Nicotinamide riboside)

Recruiting
  • Vascular Diseases
  • +3 more
  • Nicotinamide riboside
  • Aurora, Colorado
    UColorado
Jan 6, 2022

Hypertension, Aging Trial in Boulder (Nicotinamide riboside, Placebo)

Recruiting
  • Hypertension
  • Aging
  • Nicotinamide riboside
  • Placebo
  • Boulder, Colorado
    Integrative Physiology of Aging Laboratory
Feb 14, 2022

Sarcopenia, Nicotinamide Adenine Dinucleotide Concentration, Muscle Quality and NAD+ Content Trial in Buffalo (Nicotinamide

Recruiting
  • Sarcopenia
  • +2 more
  • Nicotinamide Riboside
  • Placebo
  • Buffalo, New York
    VA Western New York Healthcare System, Buffalo, NY
Oct 19, 2021

Acute Lymphoblastic Leukemia, Pediatric Trial in Worldwide (Blinatumomab, Bortezomib, Cyclophosphamide)

Recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • Sydney, Australia
  • +114 more
Nov 1, 2022

Mitochondrial Health and Hemodynamic Instability Related to

Recruiting
  • Acute Kidney Injury (AKI)
    • Ottawa, Ont, Canada
      The Ottawa Hospital
    Feb 28, 2022

    Mitochondrial Myopathies Trial in Helsinki (Niacin)

    Completed
    • Mitochondrial Myopathies
    • Niacin
    • Helsinki, Finland
      University of Helsinki
    Jan 21, 2021

    Glaucoma, Open-Angle Trial in United Kingdom (Nicotinomide, Matching )

    Not yet recruiting
    • Glaucoma, Open-Angle
    • Belfast, Northern Ireland, United Kingdom
    • +6 more
    Nov 15, 2022

    Migraine Prophylaxis Trial in Dhaka (Nicotinic Acid 500 MG Extended Release Oral Tablet, Nicotinic Acid 1000 MG Extended Release

    Recruiting
    • Migraine Prophylaxis
    • Nicotinic Acid 500 MG Extended Release Oral Tablet
    • +2 more
    • Dhaka, Bangladesh
      BSMMU
    May 5, 2023

    NAD+/NADH in Peripheral Blood Samples of Different Gender and

    Not yet recruiting
    • NAD+/NADH in Peripheral Blood Monitoring
    • Detection of NAD+/NADH concentration of Peripheral Blood Samples
    • Shanghai, Shanghai, China
      Shanghai Mengchao Cancer Hospital
    Aug 11, 2023

    Healthy Trial in Bergen (nicotinamide riboside, nicotinamide mononucleotide)

    Recruiting
    • Healthy
    • nicotinamide riboside
    • nicotinamide mononucleotide
    • Bergen, Vestland, Norway
      Haukeland University Hospital
    Jan 25, 2023

    Menopause Trial in Mobile (BASIS™ (Crystalline Nicotinamide Riboside 250mg and Pterostilbene 50mg))

    Completed
    • Menopause
    • BASIS™ (Crystalline Nicotinamide Riboside 250mg and Pterostilbene 50mg)
    • Mobile, Alabama
      University of South Alabama
    Nov 17, 2021

    Chemo-induced Peripheral Neuropathy, Breast Cancer Metastatic, Platinum-resistant Recurrent Ovarian Cancer Trial in Iowa City,

    Recruiting
    • Chemotherapy-induced Peripheral Neuropathy
    • +2 more
    • Nicotinamide Riboside
    • Iowa City, Iowa
    • +1 more
    Apr 26, 2021

    Hypertension Trial in Guangzhou (Nicotinamide mononucleotide supplied as 400mg capsule, Lifestyle modification)

    Recruiting
    • Hypertension
    • Nicotinamide mononucleotide supplied as 400mg capsule
    • Lifestyle modification
    • Guangzhou, Guangdong, China
      First Affiliated Hospital,Sun Yat-sen University
    Jan 17, 2022